Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

DVBIC blood plasma study assists in TBI and PTSD diagnosis

Image of DVBIC blood plasma study assists in TBI and PTSD diagnosis. DVBIC blood plasma study assists in TBI and PTSD diagnosis

For many years, researchers have looked for objective measures to help diagnose traumatic brain injury or post-traumatic stress disorders.

Information from the Defense and Veterans Brain Injury Center’s 15-year natural history study is assisting medical researchers in determining whether a protein found in a patient’s blood could be a promising candidate for future diagnostic tools.

A blow to the head is one of the ways a service members can sustain a TBI, and after witnessing psychologically disturbing events, they may also experience PTSD. Diagnosing these can be complex as they have similar symptoms that can be compounded when both are present.

Since 2000, more than 400,000 active-duty service members have been diagnosed with TBI, according to figures from DVBIC, the Department Department’s center of excellence for traumatic brain injury and a division of the Defense Health Agency Research and Development Directorate. However, a statistic revealing those co-presenting with PTSD has not been compiled.

In a 2018 research review on mild TBI (mTBI) and PTSD, the DVBIC noted that “differential diagnosis will likely continue to be a challenge.

Jessica Gill, a researcher at the National Institutes of Health, and Dr. Kimbra Kenney, an associate professor of neurology at the Uniformed Services University of the Health Sciences, both located in Bethesda, Maryland, are currently examining patients’ blood to see whether it can help in diagnosing and treating TBI.

“By pairing advances in the laboratory we are now able to detect very small proteins in the blood that provide key insights into pathology that contribute to long-term symptoms in military personnel and veterans with TBIs, as well with PTSDs,” said Gill.

At a recent conference, Kenney explained how specific types of blood proteins were significantly elevated among those with concussions, compared to subjects who had been deployed but not sustained TBIs. Blood samples are being collected at Walter Reed National Military Medical Center as part of their research in a study of the natural history of TBI funded by the DOD and Department of Veterans Affairs.

In another project using data from the 15-year natural history study, researchers are examining blood proteins in subjects who had both sustained a TBI and reported PTSD symptoms. Earlier studies had shown that tau and amyloid-beta-42 proteins indicated the presence of TBI; now researchers believe the presence of both proteins could reveal individuals with both TBI and PTSD.

Study participants consisted of 107 service members. Evidence of TBI was obtained from medical records and interviews at Walter Reed Bethesda. Most participants were diagnosed with a mild traumatic brain injury while the remaining subjects experienced an injury unrelated to TBI but did not lose consciousness. Each participant provided a blood sample and completed a detailed questionnaire. Three groups were formed: those with both TBI and PTSD; those with some other injury and no PTSD; and those with TBI but no PTSD.

The researchers found “tau in plasma is significantly elevated in military personnel who have sustained an mTBI and display concurrent PTSD symptomology.” This finding agrees with earlier civilian studies. Following a TBI, tau elevations are associated with poor recoveries and greater neurological problems.

These studies may show relationships between neurological outcomes and changes at the molecular level. “The novel design of the 15-year study provides the first longitudinal data to untangle complex pathological processes that result in lasting neurological and psychological symptoms and impairments,” Gill said. “By better understanding these processes, we can personalize the care we provide to treat military personnel and veterans to have the biggest impact on their health and well-being.”


You also may be interested in...

Publication
Apr 12, 2024

June 20, 2024, TBICoE QES Event: Left of the Boom

.PDF | 124.02 KB

Maintaining warfighter brain health is a top priority in the readiness and resiliency of service members. Join us for a discussion on optimizing brain health through reduction of risk and prevention of traumatic brain injury.

Publication
Mar 28, 2024

TBICoE Research Review: Multiple TBI/Multiple Concussion

.PDF | 284.05 KB

Prior history of TBI may predispose an individual to increased risk of subsequent TBI, which may result from less force, and lengthier recovery from post-injury symptoms. Activities such as contact sports and military service carry particular risk for multiple TBI.

Publication
Mar 5, 2024

Assessment and Management of Headache Following Concussion/ Mild TBI Clinical Recommendation

.PDF | 1.12 MB

This clinical recommendation, newly revised in 2024, includes specific recommendations of both pharmacologic and non-pharmacologic treatment of the most common types of post-traumatic headache, two additional PTH subtypes, and expanded information on medication overuse headache.

Publication
Feb 23, 2024

Progressive Return to Activity: Primary Care for Acute Concussion Management

.PDF | 472.50 KB

This clinical recommendation is an evidence-based return to activity protocol for primary care managers and concussion/traumatic brain injury clinic providers. The PRA is a six-step approach that begins after the provider performs the MACE 2 (Military Acute Concussion Evaluation 2) and the patient is diagnosed with a concussion, also known as a mild TBI.

Publication
Feb 23, 2024

Assessment and Management of Dizziness and Visual Disturbances Following Concussion/Mild Traumatic Brain Injury

.PDF | 1.03 MB

This clinical recommendation provides medical staff with a single, comprehensive reference for the assessment and management of dizziness and visual disturbances following mild TBI/concussion. Dizziness and visual disturbances often present with overlapping symptoms and should prompt a provider to perform a visual and dizziness—or vestibular—assessment.

Publication
Dec 14, 2023

2024 TBICoE Quarterly Education Series Schedule

.PDF | 209.46 KB

Save the dates with a complete 2024 schedule of the Traumatic Brain Injury Center of Excellence's Quarterly Education Series. The QES is an enterprise-wide learning opportunity for Military Health System stakeholders. Since inception, the QES provides trainings and education events that are relevant to the MHS, discussing specialty topics and current ...

Publication
Dec 4, 2023

Acute Concussion Care Pathway: MACE 2 and PRA Training Flier

.PDF | 228.63 KB

The Traumatic Brain Injury Center of Excellence is hosting a combined Military Acute Concussion Evaluation and Progressive Return to Activity clinical recommendation virtual training. Attendees may earn two CEUs through the Defense Health Agency Continuing Education Program Office. Download the flier for the complete 2024 training schedule.

Publication
Nov 29, 2023

TBICoE's Low-Level Blast Research Efforts Infographic

.PDF | 2.12 MB

This infographic illustrates TBICoE's work to better understand how low-level blast influences warfighter brain health. These efforts directly support Line of Effort 2 of the Warfighter Brain Health Initiative.

Skip subpage navigation
Refine your search
Last Updated: September 01, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery